Cardiac Cell Remodeling in Obesity and Diabetes.

Q1 Pharmacology, Toxicology and Pharmaceutics
Avelino-Cruz José Everardo, Yang-Bennett Daniela Sarahi, Galindo-Ramírez Fabián
{"title":"Cardiac Cell Remodeling in Obesity and Diabetes.","authors":"Avelino-Cruz José Everardo, Yang-Bennett Daniela Sarahi, Galindo-Ramírez Fabián","doi":"10.1007/164_2026_789","DOIUrl":null,"url":null,"abstract":"<p><p>The contractile activity of the heart depends on the coordinated activation of cardiac muscle cells, as well as the activation of each region within these cells. The conversion of an electrical signal into a mechanical process is known as excitation-contraction coupling; this process depends on the accurate organization and functional coupling between the different participating structures. The T-tubules and the sarcoplasmic reticulum constitute the dyads, a functional structure where the activity of voltage-gated calcium channels is coupled with the type 2 ryanodine receptor to generate calcium-induced calcium release. This phenomenon increases the intracellular calcium concentration, allowing cell contraction. The relaxation process occurs at the same time as calcium extrusion or recapture into the sarcoplasmic reticulum. The formation of the T tubules, the organization of the dyad, and the distribution of the proteins that regulate the entry, reuptake, and extrusion of calcium involve different structural proteins whose expression, localization, and function can be affected in pathological processes such as heart failure. In this chapter, we give an overview of the proteins involved in cardiac cell ultrastructural organization and an insight into changes and possible causes of these changes found in diabetes, obesity, and heart failure models.</p>","PeriodicalId":12859,"journal":{"name":"Handbook of experimental pharmacology","volume":" ","pages":"65-87"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Handbook of experimental pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/164_2026_789","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The contractile activity of the heart depends on the coordinated activation of cardiac muscle cells, as well as the activation of each region within these cells. The conversion of an electrical signal into a mechanical process is known as excitation-contraction coupling; this process depends on the accurate organization and functional coupling between the different participating structures. The T-tubules and the sarcoplasmic reticulum constitute the dyads, a functional structure where the activity of voltage-gated calcium channels is coupled with the type 2 ryanodine receptor to generate calcium-induced calcium release. This phenomenon increases the intracellular calcium concentration, allowing cell contraction. The relaxation process occurs at the same time as calcium extrusion or recapture into the sarcoplasmic reticulum. The formation of the T tubules, the organization of the dyad, and the distribution of the proteins that regulate the entry, reuptake, and extrusion of calcium involve different structural proteins whose expression, localization, and function can be affected in pathological processes such as heart failure. In this chapter, we give an overview of the proteins involved in cardiac cell ultrastructural organization and an insight into changes and possible causes of these changes found in diabetes, obesity, and heart failure models.

肥胖和糖尿病的心肌细胞重塑。
心脏的收缩活动取决于心肌细胞的协调激活,以及这些细胞内每个区域的激活。电信号转换为机械过程称为激励-收缩耦合;这一过程依赖于不同参与结构之间的准确组织和功能耦合。t小管和肌浆网构成双体,这是一种功能结构,其中电压门控钙通道的活性与2型ryanodine受体相结合,产生钙诱导的钙释放。这种现象增加了细胞内钙浓度,使细胞收缩。松弛过程发生在钙挤压或重新进入肌浆网的同时。T小管的形成、二分体的组织以及调节钙的进入、再摄取和挤压的蛋白质分布涉及不同的结构蛋白,其表达、定位和功能在诸如心力衰竭等病理过程中会受到影响。在本章中,我们概述了参与心脏细胞超微结构组织的蛋白质,并深入了解在糖尿病、肥胖和心力衰竭模型中发现的这些变化及其可能的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Handbook of experimental pharmacology
Handbook of experimental pharmacology Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.20
自引率
0.00%
发文量
54
期刊介绍: The Handbook of Experimental Pharmacology is one of the most authoritative and influential book series in pharmacology. It provides critical and comprehensive discussions of the most significant areas of pharmacological research, written by leading international authorities. Each volume in the series represents the most informative and contemporary account of its subject available, making it an unrivalled reference source.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书